Combination therapy using tPA and edaravone improves the neurotoxic effect of tPA

Interventional Neuroradiology

Volumn 13, Issue SUPPL. 1, 2007, Pages 106-108

  Kano, Tsuneo ^a   Harada, T ^a   Hirayama, T ^a   Katayama, Y ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Edaravone; Neurotoxicity; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; NORPHENAZONE; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN BLOOD VESSEL; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EXTRAVASATION; DRUG POTENTIATION; FIBRINOLYSIS; LASER DOPPLER FLOWMETRY; MALE; NEUROTOXICITY; NONHUMAN; RAT; RECANALIZATION;

EID: 34250769885     PISSN: 11239344     EISSN: None     Source Type: Journal    
DOI: 10.1177/15910199070130s115     Document Type: Conference Paper

References (6)

1. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587, 1995.
2. Wang YF, Tsirka SE et Al: Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nature Med 4: 228-231, 1998.
3. Kano T, Katayama Y et Al: Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Brain Res 854: 245-248, 2000.
4. Ranby M, Nguyen G et Al: Immunoreactivity of tissue plasminogen activator and its inhibitor complexes. Thromb Haemostas 61: 409-414, 1989.
5. Watanabe T, Yuki S et Al: Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268: 1597-1604, 1994.
6. Flavin MP, Zhao G, Ho LT: Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29: 347-354, 2000.